| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.32 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |